Evidence-Based Treatment of Patients with Common Nail Disorders
213402134021340
At the 2024 ODAC Dermatology, Aesthetic & Surgical Conference, we had the opportunity to learn about treating common nail disorders from Dr. Molly A. Hinshaw, MD, FAAD, Director of Nail Clinic, Section Chief of Dermatopathology, and Professor of Dermatology at the University of Wisconsin School of Medicine. Nail conditions can markedly decrease the quality of life for patients not only due to …
At the 2024 ODAC Dermatology, Aesthetic & Surgical Conference, we had the opportunity to learn about treating common nail disorders from Dr. Molly A. Hinshaw, MD, FAAD, Director of Nail Clinic, Section Chief of Dermatopathology, and Professor of Dermatology at the University of Wisconsin School of Medicine. Nail conditions can markedly decrease the quality of life for patients not only due to … Continue reading "Evidence-Based Treatment of Patients with Common Nail Disorders"
Next Steps in Derm, in partnership with Skin of Color Update, interviewed Dr. Shari Lipner, director of the Nail Division at the New York-Presbyterian Hospital/Weill Cornell Medical Center. Hear the results of Dr. Lipner’s retrospective study on time to diagnosis in patients with skin of color who have nail psoriasis. Find out why the clinical examination is especially important. Learn how derm … 
Bimekizumab (Bimzelx®) is a new injectable medication FDA approved for plaque psoriasis. It is the first and only FDA approved IL-17A and IL-17F inhibitor for this disease, but is also being used as an off-label option for other conditions including psoriatic arthritis and hidradenitis suppurativa. This Therapeutic Cheat Sheet will focus on the on and off label uses of bimekizumab.
Bimekizuma … 
Media attention about oral minoxidil has impacted access to the hair loss drug in the Washington, D.C. area, according to a study published in the January issue of the Journal of Drugs in Dermatology. Researchers found shortages of the drug in D.C.-area pharmacies more than a year after an article about the treatment appeared in The New York Times.
To find out more about oral minoxidil access, … 
Pretibial myxedema (PTM) is a rare complication of Graves' disease. It is characterized by non-pitting edema with hyperpigmented hyperkeratotic papules and plaques on bilateral lower legs. Effective treatments for patients with PTM are lacking. The etiology of PTM is unknown; however, it may be similar to the mechanism of thyroid-associated ophthalmopathy (TAO). Activated fibroblasts produce infla … 